Analysis of Long-term (Investment) Activity Ratios
Activity ratios measure how efficiently a company performs day-to-day tasks, such us the collection of receivables and management of inventory.
Long-term Activity Ratios (Summary)
Abiomed Inc., long-term (investment) activity ratios
Based on: 10-K (reporting date: 2022-03-31), 10-K (reporting date: 2021-03-31), 10-K (reporting date: 2020-03-31), 10-K (reporting date: 2019-03-31), 10-K (reporting date: 2018-03-31), 10-K (reporting date: 2017-03-31).
| Long-term activity ratio | Description | The company |
|---|---|---|
| Net fixed asset turnover | An activity ratio calculated as total revenue divided by net fixed assets. | Abiomed Inc. net fixed asset turnover ratio deteriorated from 2020 to 2021 but then improved from 2021 to 2022 not reaching 2020 level. |
| Net fixed asset turnover (including operating lease, right-of-use asset) | An activity ratio calculated as total revenue divided by net fixed assets (including operating lease, right-of-use asset). | Abiomed Inc. net fixed asset turnover ratio (with operating lease, right-of-use asset) deteriorated from 2020 to 2021 but then improved from 2021 to 2022 exceeding 2020 level. |
| Total asset turnover | An activity ratio calculated as total revenue divided by total assets. | Abiomed Inc. total asset turnover ratio deteriorated from 2020 to 2021 but then slightly improved from 2021 to 2022. |
| Equity turnover | An activity ratio calculated as total revenue divided by shareholders’ equity. | Abiomed Inc. equity turnover ratio deteriorated from 2020 to 2021 but then slightly improved from 2021 to 2022. |
Net Fixed Asset Turnover
Abiomed Inc., net fixed asset turnover calculation, comparison to benchmarks
| Mar 31, 2022 | Mar 31, 2021 | Mar 31, 2020 | Mar 31, 2019 | Mar 31, 2018 | Mar 31, 2017 | ||
|---|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in thousands) | |||||||
| Revenue | 1,031,753) | 847,522) | 840,883) | 769,432) | 593,749) | 445,304) | |
| Property and equipment, net | 202,490) | 197,129) | 164,931) | 145,005) | 117,167) | 87,777) | |
| Long-term Activity Ratio | |||||||
| Net fixed asset turnover1 | 5.10 | 4.30 | 5.10 | 5.31 | 5.07 | 5.07 | |
| Benchmarks | |||||||
| Net Fixed Asset Turnover, Competitors2 | |||||||
| Abbott Laboratories | 4.76 | 4.81 | 3.83 | 3.97 | — | — | |
| Cigna Group | 47.53 | 46.73 | 37.85 | 34.45 | — | — | |
| CVS Health Corp. | 24.98 | 22.56 | 21.25 | 21.24 | — | — | |
| Elevance Health Inc. | 36.07 | 34.94 | 34.69 | 32.92 | — | — | |
| Humana Inc. | 28.71 | 26.97 | 32.05 | 32.93 | — | — | |
| Intuitive Surgical Inc. | 2.62 | 3.04 | 2.76 | 3.52 | — | — | |
| Medtronic PLC | 5.85 | 5.77 | 5.99 | 6.54 | — | — | |
| UnitedHealth Group Inc. | 31.81 | 31.81 | 29.64 | 27.60 | — | — | |
| Net Fixed Asset Turnover, Sector | |||||||
| Health Care Equipment & Services | 22.49 | 21.55 | 20.28 | 19.95 | — | — | |
| Net Fixed Asset Turnover, Industry | |||||||
| Health Care | 10.64 | 10.41 | 9.64 | 9.74 | — | — | |
Based on: 10-K (reporting date: 2022-03-31), 10-K (reporting date: 2021-03-31), 10-K (reporting date: 2020-03-31), 10-K (reporting date: 2019-03-31), 10-K (reporting date: 2018-03-31), 10-K (reporting date: 2017-03-31).
1 2022 Calculation
Net fixed asset turnover = Revenue ÷ Property and equipment, net
= 1,031,753 ÷ 202,490 = 5.10
2 Click competitor name to see calculations.
| Long-term activity ratio | Description | The company |
|---|---|---|
| Net fixed asset turnover | An activity ratio calculated as total revenue divided by net fixed assets. | Abiomed Inc. net fixed asset turnover ratio deteriorated from 2020 to 2021 but then improved from 2021 to 2022 not reaching 2020 level. |
Net Fixed Asset Turnover (including Operating Lease, Right-of-Use Asset)
Abiomed Inc., net fixed asset turnover (including operating lease, right-of-use asset) calculation, comparison to benchmarks
| Mar 31, 2022 | Mar 31, 2021 | Mar 31, 2020 | Mar 31, 2019 | Mar 31, 2018 | Mar 31, 2017 | ||
|---|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in thousands) | |||||||
| Revenue | 1,031,753) | 847,522) | 840,883) | 769,432) | 593,749) | 445,304) | |
| Property and equipment, net | 202,490) | 197,129) | 164,931) | 145,005) | 117,167) | 87,777) | |
| Operating lease right-of-use assets | 9,518) | 6,109) | 11,760) | —) | —) | —) | |
| Property and equipment, net (including operating lease, right-of-use asset) | 212,008) | 203,238) | 176,691) | 145,005) | 117,167) | 87,777) | |
| Long-term Activity Ratio | |||||||
| Net fixed asset turnover (including operating lease, right-of-use asset)1 | 4.87 | 4.17 | 4.76 | 5.31 | 5.07 | 5.07 | |
| Benchmarks | |||||||
| Net Fixed Asset Turnover (including Operating Lease, Right-of-Use Asset), Competitors2 | |||||||
| Abbott Laboratories | 4.25 | 4.26 | 3.42 | 3.56 | — | — | |
| Cigna Group | 43.23 | 41.37 | 33.46 | 30.72 | — | — | |
| CVS Health Corp. | 10.46 | 9.09 | 8.04 | 7.77 | — | — | |
| Elevance Health Inc. | 31.64 | 30.12 | 29.26 | 27.82 | — | — | |
| Humana Inc. | 24.76 | 22.09 | 27.07 | 27.22 | — | — | |
| Intuitive Surgical Inc. | 2.53 | 2.93 | 2.66 | 3.32 | — | — | |
| Medtronic PLC | 5.06 | 4.84 | 5.02 | 6.54 | — | — | |
| UnitedHealth Group Inc. | 21.54 | 21.54 | 19.55 | 18.97 | — | — | |
| Net Fixed Asset Turnover (including Operating Lease, Right-of-Use Asset), Sector | |||||||
| Health Care Equipment & Services | 14.87 | 13.78 | 12.53 | 12.33 | — | — | |
| Net Fixed Asset Turnover (including Operating Lease, Right-of-Use Asset), Industry | |||||||
| Health Care | 8.57 | 8.24 | 7.56 | 7.64 | — | — | |
Based on: 10-K (reporting date: 2022-03-31), 10-K (reporting date: 2021-03-31), 10-K (reporting date: 2020-03-31), 10-K (reporting date: 2019-03-31), 10-K (reporting date: 2018-03-31), 10-K (reporting date: 2017-03-31).
1 2022 Calculation
Net fixed asset turnover (including operating lease, right-of-use asset) = Revenue ÷ Property and equipment, net (including operating lease, right-of-use asset)
= 1,031,753 ÷ 212,008 = 4.87
2 Click competitor name to see calculations.
| Long-term activity ratio | Description | The company |
|---|---|---|
| Net fixed asset turnover (including operating lease, right-of-use asset) | An activity ratio calculated as total revenue divided by net fixed assets (including operating lease, right-of-use asset). | Abiomed Inc. net fixed asset turnover ratio (with operating lease, right-of-use asset) deteriorated from 2020 to 2021 but then improved from 2021 to 2022 exceeding 2020 level. |
Total Asset Turnover
Abiomed Inc., total asset turnover calculation, comparison to benchmarks
| Mar 31, 2022 | Mar 31, 2021 | Mar 31, 2020 | Mar 31, 2019 | Mar 31, 2018 | Mar 31, 2017 | ||
|---|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in thousands) | |||||||
| Revenue | 1,031,753) | 847,522) | 840,883) | 769,432) | 593,749) | 445,304) | |
| Total assets | 1,673,393) | 1,494,359) | 1,216,462) | 1,054,346) | 786,375) | 550,414) | |
| Long-term Activity Ratio | |||||||
| Total asset turnover1 | 0.62 | 0.57 | 0.69 | 0.73 | 0.76 | 0.81 | |
| Benchmarks | |||||||
| Total Asset Turnover, Competitors2 | |||||||
| Abbott Laboratories | 0.59 | 0.57 | 0.48 | 0.47 | — | — | |
| Cigna Group | 1.25 | 1.11 | 1.02 | 0.98 | — | — | |
| CVS Health Corp. | 1.41 | 1.25 | 1.16 | 1.15 | — | — | |
| Elevance Health Inc. | 1.51 | 1.41 | 1.39 | 1.33 | — | — | |
| Humana Inc. | 2.15 | 1.87 | 2.17 | 2.21 | — | — | |
| Intuitive Surgical Inc. | 0.48 | 0.42 | 0.39 | 0.46 | — | — | |
| Medtronic PLC | 0.35 | 0.32 | 0.32 | 0.34 | — | — | |
| UnitedHealth Group Inc. | 1.31 | 1.34 | 1.30 | 1.38 | — | — | |
| Total Asset Turnover, Sector | |||||||
| Health Care Equipment & Services | 1.22 | 1.13 | 1.08 | 1.07 | — | — | |
| Total Asset Turnover, Industry | |||||||
| Health Care | 0.82 | 0.76 | 0.70 | 0.71 | — | — | |
Based on: 10-K (reporting date: 2022-03-31), 10-K (reporting date: 2021-03-31), 10-K (reporting date: 2020-03-31), 10-K (reporting date: 2019-03-31), 10-K (reporting date: 2018-03-31), 10-K (reporting date: 2017-03-31).
1 2022 Calculation
Total asset turnover = Revenue ÷ Total assets
= 1,031,753 ÷ 1,673,393 = 0.62
2 Click competitor name to see calculations.
| Long-term activity ratio | Description | The company |
|---|---|---|
| Total asset turnover | An activity ratio calculated as total revenue divided by total assets. | Abiomed Inc. total asset turnover ratio deteriorated from 2020 to 2021 but then slightly improved from 2021 to 2022. |
Equity Turnover
Abiomed Inc., equity turnover calculation, comparison to benchmarks
| Mar 31, 2022 | Mar 31, 2021 | Mar 31, 2020 | Mar 31, 2019 | Mar 31, 2018 | Mar 31, 2017 | ||
|---|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in thousands) | |||||||
| Revenue | 1,031,753) | 847,522) | 840,883) | 769,432) | 593,749) | 445,304) | |
| Stockholders’ equity | 1,503,326) | 1,329,675) | 1,065,466) | 936,890) | 689,524) | 452,071) | |
| Long-term Activity Ratio | |||||||
| Equity turnover1 | 0.69 | 0.64 | 0.79 | 0.82 | 0.86 | 0.99 | |
| Benchmarks | |||||||
| Equity Turnover, Competitors2 | |||||||
| Abbott Laboratories | 1.19 | 1.20 | 1.06 | 1.03 | — | — | |
| Cigna Group | 4.00 | 3.66 | 3.16 | 3.36 | — | — | |
| CVS Health Corp. | 4.53 | 3.87 | 3.86 | 4.00 | — | — | |
| Elevance Health Inc. | 4.29 | 3.80 | 3.64 | 3.25 | — | — | |
| Humana Inc. | 6.04 | 5.15 | 5.54 | 5.35 | — | — | |
| Intuitive Surgical Inc. | 0.56 | 0.48 | 0.45 | 0.54 | — | — | |
| Medtronic PLC | 0.60 | 0.59 | 0.57 | 0.61 | — | — | |
| UnitedHealth Group Inc. | 4.14 | 3.98 | 3.90 | 4.17 | — | — | |
| Equity Turnover, Sector | |||||||
| Health Care Equipment & Services | 3.34 | 3.03 | 2.91 | 2.94 | — | — | |
| Equity Turnover, Industry | |||||||
| Health Care | 2.20 | 2.11 | 2.08 | 2.08 | — | — | |
Based on: 10-K (reporting date: 2022-03-31), 10-K (reporting date: 2021-03-31), 10-K (reporting date: 2020-03-31), 10-K (reporting date: 2019-03-31), 10-K (reporting date: 2018-03-31), 10-K (reporting date: 2017-03-31).
1 2022 Calculation
Equity turnover = Revenue ÷ Stockholders’ equity
= 1,031,753 ÷ 1,503,326 = 0.69
2 Click competitor name to see calculations.
| Long-term activity ratio | Description | The company |
|---|---|---|
| Equity turnover | An activity ratio calculated as total revenue divided by shareholders’ equity. | Abiomed Inc. equity turnover ratio deteriorated from 2020 to 2021 but then slightly improved from 2021 to 2022. |